 ##  [Radioligand Therapy Production in Winter Park, FL](/us-en/radioligand-therapy-production-winter-park-florida "Radioligand Therapy Production in Winter Park, FL") 

  ![radioligand therapy manufacturing facility in Winter Park, Florida](/us-en/sites/novartis_us/files/styles/cta_image/public/2026-01/Radioligand%20therapy%20manufacturing%20facility%20in%20Winter%20Park%2C%20Florida.jpg.webp?itok=g4nR7xB9 "radioligand therapy manufacturing facility in Winter Park, Florida") 

 

Once completed in 2029, our new 35,000-square-foot radioligand therapy (RLT) site in Winter Park, Florida will expand our manufacturing footprint and optimize the delivery of RLT medicines to patients in the southeast US.

RLT is a type of precision treatment that pairs a tumor-targeting molecule (ligand) with a therapeutic radioisotope, allowing radiation to be delivered directly to the tumor while minimizing harm to surrounding healthy tissue.



 

 



 





##  Key Facts About the Site 

 2029 

site expected to open

 

 35K 

square-foot site 

 

 1 of 5 

US RLT manufacturing sites 

 

 







 ![scientists fist bumping ](/us-en/sites/novartis_us/files/styles/cta_image/public/2026-03/BJORN_NOVARTIS_RLT%20-%20Main%20Sequence%20RePurpose%202%20271025%20AM%20V1.00_00_58_12.Still029.jpg.webp?itok=1X4xkaL8 "Investing in America Hero") 

 



## Explore Career Opportunities in Winter Park

From science roles to manufacturing to business, find the right role at Novartis in the US and join us as we work to reimagine medicine.



 

 





 

 [Learn More](https://www.novartis.com/careers/career-search?search_api_fulltext=Winter+Park&functional_area%5B%5D=FCT_PR&functional_area%5B%5D=FCT_QA&functional_area%5B%5D=FCT_TO&country%5B%5D=LOC_US&field_job_posted_date=All&op=Submit "Learn More") 



 

 



 





##  Featured Stories 

 [ 

 ![Portrait of Thierry Diagana, California Site Head for Novartis Biomedical Research, wearing black sweater and white collared shirt](/us-en/sites/novartis_us/files/styles/cards_1_3/public/2025-08/Q%26A_banner_v3_1.png.webp?itok=GMCshGUd "thierry-diagana-novartis-california-site-head-portrait") 

 

###  Designing for the Future: The Next Era of Biomedical Research in San Diego 

Thierry Diagana, California Sites Head at Novartis, shares the vision for a new research hub that will power future drug discovery.

 

 

 ](https://www.novartis.com/us-en/stories/novartis-biomedical-research-hub-san-diego-thierry-diagana) [ 

 ![Team shot at the groundbreaking, with shovels in sand. ](/us-en/sites/novartis_us/files/styles/cards_1_3/public/2026-04/1.%20Ground%20Breaking%20Shot.jpg.webp?itok=__w3U0mi "Team shot at the groundbreaking, with shovels in sand. ") 

 

###  Innovating for America: How Our New RLT Manufacturing Site Can Help Ensure Continued On Time Delivery to Patients Now and in Future 

As Novartis expands its manufacturing capabilities, our new Carlsbad facility will help deliver time-sensitive cancer treatments to patients, meeting future demand.

 

 

 ](https://www.novartis.com/us-en/stories/innovating-america-new-rlt-manufacturing-site) [ 

 ![A Novartis employee and Veteran, Matt Baca, featured during his time in the military.](/us-en/sites/novartis_us/files/styles/cards_1_3/public/2025-10/Mattinprofile.png.webp?itok=qayVJj8I "A Novartis employee and Veteran, Matt Baca, featured during his time in the military.") 

 

###  How This Former Army Officer Helps Deliver Cancer Treatments to Patients 

Radioligand therapies harness the power of radioisotopes to target cancer with precision. For Matt Baca, delivering a dose in a three-to-five-day window is all in a day’s work.

 

 

 ](https://www.novartis.com/us-en/stories/veteran-delivers-cancer-treatment-to-patients) 





 

 

 



##  Latest News 

 [Jan 09, 2026

- Media Release

 

###  Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

 ](/us-en/news/media-releases/novartis-add-radioligand-therapy-manufacturing-facility-winter-park-florida-fourth-us-serve-patients-and-advance-23-billion-investment) [Feb 25, 2026

- Media Release

 

###  Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients

 ](/us-en/news/media-releases/novartis-build-new-radioligand-therapy-site-denton-texas-delivering-more-next-generation-treatments-patients) [Nov 10, 2025

- Media Release

 

###  Novartis opens new radioligand therapy manufacturing facility in California as part of $23B US expansion plan

 ](/us-en/news/media-releases/novartis-opens-new-radioligand-therapy-manufacturing-facility-california-part-23b-us-expansion-plan) 





 

 [View More](https://www.novartis.com/us-en/news/news-archive "View More") 

 





##  See Our Other US Sites 

 

   Previous    Next  

 

 [ ![Biomedical Research organization in Cambridge, Massachusetts](/us-en/sites/novartis_us/files/styles/cards_1_3/public/2025-09/Biomedical-Research-organization-in-Cambridge-Massachusetts.png.webp?itok=5KRHlit5 "Biomedical-Research-organization-in-Cambridge-Massachusetts")

 



 

###  Cambridge, MA 

This Biomedical Research organization, established in 2003, is dedicated to scientific innovation and drug discovery.

 

 ](https://www.novartis.com/us-en/biomedical-research-organization-cambridge-ma) 

 

 [ ![Novartis Radioligand Therapy Production Carlsbad California](/us-en/sites/novartis_us/files/styles/cards_1_3/public/2025-09/Carlsbad%2C%20California.JPG.webp?itok=GzVy9Yv3 "Novartis Radioligand Therapy Production Carlsbad California")

 



 

###  Carlsbad, CA 

Our third US radioligand therapy manufacturing site opened in 2025 and serves patients across the western US, Alaska and Hawaii.

 

 ](https://www.novartis.com/us-en/radioligand-therapy-production-carlsbad-ca) 

 

 [ ![Scientist working in a laboratory with test tubes and scientific equipment](/us-en/sites/novartis_us/files/styles/cards_1_3/public/2026-04/Scientist%20working%20in%20a%20laboratory%20with%20test%20tubes%20and%20scientific%20equipment.jpeg.webp?itok=OKKyXm55 "Scientist working in a laboratory with test tubes and scientific equipment")

 



 

###  Denton, TX 

Expected to become fully operational in 2028, our fifth US radioligand manufacturing site will serve patients in the southern US. 

 

 ](https://www.novartis.com/us-en/radioligand-therapy-production-denton-tx) 

 

 [ ![Novartis Gene Therapy Production, Durham, NC](/us-en/sites/novartis_us/files/styles/cards_1_3/public/2025-12/Novartis%20Gene%20Therapy%20Production%20Durham%2C%20NC.png.webp?itok=-WQCWXPk "Novartis Gene Therapy Production, Durham, NC")

 



 

###  Durham, NC (14TW) 

Expected to be operational in 2028, the site will house two new facilities for manufacturing biologics and sterile packaging. 

 

 ](https://www.novartis.com/us-en/14tw-biologics-production-durham-nc) 

 

 [ ![Novartis Gene Therapy Production Durham North Carolina](/us-en/sites/novartis_us/files/styles/cards_1_3/public/2025-09/Durham%2C%20North%20Carolina.jpg.webp?itok=rm8Uw4Yr "Novartis Gene Therapy Production Durham North Carolina")

 



 

###  Durham, NC (TriCenter) 

The site produces innovative gene therapies and is expanding to support sterile filling of biologics into syringes and vials. 

 

 ](https://www.novartis.com/us-en/tricenter-gene-therapy-production-durham-nc) 

 

 [ ![Novartis Radioligand Therapy Production Indianapolis Indiana](/us-en/sites/novartis_us/files/styles/cards_1_3/public/2025-09/Indianapolis%2C%20Indiana_0.jpg.webp?itok=LXoGnbGT "Novartis Radioligand Therapy Production Indianapolis Indiana")

 



 

###  Indianapolis, IN 

Our second US radioligand therapy manufacturing site opened in 2024. Expansion of the site is ongoing.

 

 ](https://www.novartis.com/us-en/radioligand-therapy-production-indianapolis) 

 

 [ ![Novartis Radioligand Therapy Production Millburn New Jersey](/us-en/sites/novartis_us/files/styles/cards_1_3/public/2025-09/Millburn%2C%20New%20Jersey.JPG.webp?itok=hXJ9CeAC "Novartis Radioligand Therapy Production Millburn New Jersey")

 



 

###  Millburn, NJ 

Our first US radioligand therapy manufacturing site opened in 2023. Its on-site production capabilities continue to expand.

 

 ](https://www.novartis.com/us-en/radioligand-therapy-production-millburn) 

 

 [ ![Morrisville, North Carolina](/us-en/sites/novartis_us/files/styles/cards_1_3/public/2026-04/Morrisville%2C%20NC_0.jpg.webp?itok=rCf5foqp "Morrisville, North Carolina")

 



 

###  Morrisville, NC 

Two new facilities for production and packaging of small molecule medicines, and active pharmaceutical ingredient manufacturing.

 

 ](https://www.novartis.com/us-en/small-molecule-production-morrisville-nc) 

 

 [ ![Novartis Cell Therapy Production Morris Plains New Jersey ](/us-en/sites/novartis_us/files/styles/cards_1_3/public/2025-09/Morris%20Plains%2C%20New%20Jersey_0.jpg.webp?itok=vYv-K-wX " Novartis Cell Therapy Production Morris Plains New Jersey")

 



 

###  Morris Plains, NJ 

Since 2015, the site has specialized in the production of groundbreaking cell therapies.

 

 ](https://www.novartis.com/us-en/cell-therapy-production-morris-plains) 

 

 [ ![Novartis Biomedical Research Center in San Diego, California](/us-en/sites/novartis_us/files/styles/cards_1_3/public/2026-02/Novartis-Biomedical-Research-Center-San-Diego-California.jpg.webp?itok=sGR7oWTC "Novartis Biomedical Research Center in San Diego, California")

 



 

###  San Diego, CA 

In 2026, we broke ground on a new global Biomedical Research center designed to accelerate drug discovery.

 

 ](https://www.novartis.com/us-en/biomedical-research-center-san-diego-ca?check_logged_in=1) 

 

 





###  Learn More About Our Investment in the US 



 [Return to Investing in America’s Health](https://www.novartis.com/us-en/about/investing-americas-health "Return to Investing in America’s Health")